2/28/2007

An FDA advisory panel recommended approval of the Sanofi-Aventis bird flu vaccine, despite limited evidence of its effectiveness. Currently there are no bird flu vaccines approved for use in the U.S., and the government wants to stockpile the Sanofi-Aventis vaccine for use in a pandemic.

Related Summaries